Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Fenestrated ASD closure in a child with idiopathic pulmonary hypertension and exercise desaturation.

Hirsch R, Bagby MC, Zussman ME.

Congenit Heart Dis. 2011 Mar-Apr;6(2):162-6. doi: 10.1111/j.1747-0803.2010.00472.x.

PMID:
21426528
2.

Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension.

Fujino T, Yao A, Hatano M, Inaba T, Muraoka H, Minatsuki S, Imamura T, Maki H, Kinugawa K, Ono M, Nagai R, Komuro I.

Int Heart J. 2015;56(1):86-93. doi: 10.1536/ihj.14-183.

3.

Atrial septal defect closure with an Amplatzer septal occluder fenestrated with a coronary stent in a child with pulmonary arterial hypertension.

Skinner GJ, Tulloh RM, Tometzki AJ, Schulze-Neick I, Morgan GJ.

Cardiol Young. 2013 Oct;23(5):692-6. doi: 10.1017/S1047951112001771.

PMID:
23089055
4.

Continuous epoprostenol therapy and septal defect closure in a patient with severe pulmonary hypertension.

Hirabayashi A, Miyaji K, Akagi T.

Catheter Cardiovasc Interv. 2009 Apr 1;73(5):688-91. doi: 10.1002/ccd.21877.

PMID:
19133673
5.

Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol.

Frost AE, Quiñones MA, Zoghbi WA, Noon GP.

J Heart Lung Transplant. 2005 Apr;24(4):501-3.

PMID:
15797757
6.

Repair of atrial septal defect with Eisenmenger syndrome after long-term sildenafil therapy.

Kim YH, Yu JJ, Yun TJ, Lee Y, Kim YB, Choi HS, Jhang WK, Shin HJ, Park JJ, Seo DM, Ko JK, Park IS.

Ann Thorac Surg. 2010 May;89(5):1629-30. doi: 10.1016/j.athoracsur.2009.10.027.

PMID:
20417794
7.

The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.

Zeng WJ, Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Gu Q, Zhao ZH, Li JJ, He JG; Sildenafil Therapy on Pulmonary Arterial Hypertension Associated With Different Types of Congenital Heart Disease Study Group..

Clin Cardiol. 2011 Aug;34(8):513-8. doi: 10.1002/clc.20917.

8.

Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure.

Bradley EA, Chakinala M, Billadello JJ.

Am J Cardiol. 2013 Nov 1;112(9):1471-6. doi: 10.1016/j.amjcard.2013.07.027.

PMID:
23993122
9.

Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.

Berger RM, Beghetti M, Galiè N, Gatzoulis MA, Granton J, Lauer A, Chiossi E, Landzberg M.

Int J Cardiol. 2010 Oct 29;144(3):373-8. doi: 10.1016/j.ijcard.2009.04.037.

PMID:
19464064
10.

Atrial septal defect with severe pulmonary hypertension in elderly patients: usefulness of transient balloon occlusion.

Sánchez-Recalde A, Oliver JM, Galeote G, González A, Calvo L, Jiménez-Valero S, Moreno R, López-Sendón JL.

Rev Esp Cardiol. 2010 Jul;63(7):860-4. English, Spanish.

11.

Hemodynamic effects of vasodilator therapy in severe left heart failure combined with large atrial septal defects.

Kolibash AJ, Magorien RD, Robinson JL, Leier CV.

Am J Med. 1982 Sep;73(3):439-4.

PMID:
7124771
12.

Sinus venosus atrial septal defect in a 31-year-old female patient: a case for surgical repair.

Gatzoulis MA, Giannakoulas G.

Eur Respir Rev. 2010 Dec;19(118):340-4. doi: 10.1183/09059180.00007610.

13.

Long-term follow-up of a fenestrated Amplatzer atrial septal occluder in pulmonary arterial hypertension.

Althoff TF, Knebel F, Panda A, McArdle J, Gliech V, Franke I, Witt C, Baumann G, Borges AC.

Chest. 2008 Jan;133(1):283-5. doi: 10.1378/chest.07-1222.

PMID:
18187754
14.

Surgical strategy in patients with atrial septal defect and severe pulmonary hypertension.

Cho YH, Jun TG, Yang JH, Park PW, Huh J, Kang IS, Lee HJ.

Heart Surg Forum. 2012 Apr;15(2):E111-5. doi: 10.1532/HSF98.20111085.

PMID:
22543336
15.

Implantable atrial flow regulator for severe, irreversible pulmonary arterial hypertension.

Patel MB, Samuel BP, Girgis RE, Parlmer MA, Vettukattil JJ.

EuroIntervention. 2015 Oct;11(6):706-9. doi: 10.4244/EIJY15M07_08.

16.

Surgical repair of atrial septal defect with severe pulmonary hypertension during pregnancy: a case report with literature review.

Manivannan S, Dadlani G, Parsons M, Crisan L, Belogolovkin V, Sastry N, Guglin M.

Cardiol Young. 2012 Oct;22(5):493-8. doi: 10.1017/S1047951112000492. Review.

PMID:
22717278
17.

Hemodynamic Follow-Up in Adult Patients with Pulmonary Hypertension Associated with Atrial Septal Defect after Partial Closure.

Song J, Huh J, Lee SY, Kang IS, Lee CH, Lee C, Yang JH, Jun TG.

Yonsei Med J. 2016 Mar;57(2):306-12. doi: 10.3349/ymj.2016.57.2.306.

18.

Acute hemodynamic effects of adjustable atrial septal defect closure in the lateral tunnel Fontan procedure.

Harake B, Kuhn MA, Jarmakani JM, Laks H, al-Khatib Y, Elami A, Williams RG.

J Am Coll Cardiol. 1994 Jun;23(7):1671-6.

PMID:
8195530
19.

Reduction in recalcitrant pulmonary hypertension after operation for atrial septal defect.

Yamauchi H, Yamaki S, Fujii M, Iwaki H, Tanaka S.

Ann Thorac Surg. 2001 Sep;72(3):905-6; discussion 906-7.

PMID:
11565678
20.

Atrial septal defect in adults. Clinical and hemodynamic results of surgery.

Dave KS, Pakrashi BC, Wooler GH, Ionescu MI.

Am J Cardiol. 1973 Jan;31(1):7-13. No abstract available.

PMID:
4682414

Supplemental Content

Support Center